Skip to main content

PerkinElmer Board Declares Dividend

NEW YORK (Genomeweb News) – The board of directors of PerkinElmer has declared a quarterly dividend of $.07 per share.

The dividend is payable on May 7 to shareholders of record as of the close of business on April 16.

PerkinElmer is scheduled to release its fourth-quarter and full-year 2009 results on Feb. 4. Analysts expect, on average, the firm to report Q4 revenues of $479.5 million and earnings per share of $.41.

The Scan

Rise of B.1.617.2 in the UK

According to the Guardian, UK officials expect the B.1.617.2 variant to soon be the dominant version of SARS-CoV-2 there.

Anne Schuchat to Retire

Anne Schuchat is retiring after more than 30 years at the US Centers for Disease Control and Prevention, Politico reports.

US to Share More Vaccines

CNN reports that the US will share 20 million doses of the Moderna, Pfizer, and Johnson & Johnson SARS-CoV-2 vaccines with other countries.

PNAS Papers on Gene Therapy Platform, Aspergillus Metabolome, Undernutrition Model Microbiome

In PNAS this week: approach to deliver protein-based treatments to cells, pan-secondary metabolome of Aspergillus, and more.